DNALite Therapeutics, Inc.

DNALite Therapeutics, Inc.

DNALite Therapeutics, Inc.

DNALite Therapeutics, Inc. is an early-stage preclinical biotechnology company.
Type
B2c
Founded
2016
Raised
$1.5M
Follow us
Alexa global traffic share
Latest funding
$1,500,000
Seed fund - 2018
SOSV Berkeley Catalyst Fund University of California Berkeley +6
Undisclosed amount
Seed fund - 2017
SOSV Indie Bio
Team Size
2
Employees
$1,500,000 Seed fund
FinSMEs

Gastrointestinal Gene Therapy Biotech Company DNAlite Therapeutics Raises $1.5M

Health Funding Science